| Equity lens criterion 1 | Equity lens criterion 4 (number of comments) | Non-lens ID statement categories (number of comments) | |||
---|---|---|---|---|---|---|
 | Any groups identified at increased risk | ID identified at increased risk | Barriers to implementation | Diagnosis | Intervention | Other |
Obesity | SIGN | NICE | NICE (5) | SIGN (1) | NICE (6) | NICE (4) |
 | NICE | SIGN |  |  | SIGN (1) | SIGN (2) |
 | Australia |  |  |  |  |  |
 | USA |  |  |  |  |  |
 | Canada |  |  |  |  |  |
 | Malaysia |  |  |  |  |  |
Osteoporosis | SIGN | Â | None | None | None | None |
 | USA |  |  |  |  |  |
 | Canada |  |  |  |  |  |
 | Singapore |  |  |  |  |  |
Epilepsy | NICE | SIGN | NICE (5) | NICE (18) | NICE (12) | NICE (19) |
 | SIGN | NICE | SIGN (9) | SIGN (3) | SIGN (6) | SIGN (5) |
Obstructive sleep apnea | SIGN | Â | None | None | None | None |
 | USA |  |  |  |  |  |
Upper gastrointestinal problems | NICE | Â | None | None | None | None |
 | New Zealand |  |  |  |  |  |
 | Canada |  |  |  |  |  |
Accidents/injuries, falls | NICE | Â | None | None | None | None |
 | Canada |  |  |  |  |  |
Dementia | NICE | NICE | NICE (10) | NICE (9) | NICE (9) | NICE (4) |
 | USA |  |  |  |  |  |
 | Canada |  |  |  |  |  |
 | Singapore |  |  |  |  |  |
 | Malaysia |  |  |  |  |  |
Schizophrenia | New Zealand/Australia | Â | None | Canada (1) | None | None |
Bipolar affective disorder | SIGN | NICE | NICE (1) | NICE (1) | None | NICE (1) |
 | NICE |  |  | SIGN (1) |  | SIGN (1) |
 | Canada |  |  |  |  |  |